arrow
I

Irina Kulikovskaya

University of Pennsylvania
H指数:32
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical Trial Results Provide the Rationale to Protect Dual HIV-specific T Cells with a Signaling-Defective HIV Fusion Inhibitor

临床 trial 结果提供了保护 dual HIV-specific T cells 的 rationale,其方法是使用一种 signaling-defective HIV fusion inhibitor。

2026-01-100
PRE
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia

CD19 CAR T细胞回输预防和治疗儿童急性淋巴细胞白血病复发

2024-04-291
OAAI
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

商业CAR T细胞治疗后T细胞淋巴瘤和继发性原发性恶性肿瘤风险

2024-01-2481
PRE
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy

抗BCMA/CD19 CAR T细胞与多发性骨髓瘤的早期免疫调节维持对初始或后续治疗有反应

2022-11-2144
OAAI
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial

靶向PSMA的tgf β 不敏感的装甲CAR T细胞在转移性去势抵抗性前列腺癌中的作用: 1期试验

2022-03-21266
OA
BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia
2021-08-1658
OA
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia (vol 24, pg 563, 2018)
2021-02-0510
OAAI
CRISPR-engineered T cells in patients with refractory cancer

难治性癌症患者的CRISPR工程T细胞

Science
IF45.8
2020-01-010
OAAI
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma (vol 3, e120505, 2018)
2019-02-2143
OA
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell

通过转导单个白血病b细胞诱导对嵌合抗原受体T细胞疗法的抗性

2018-10-01511
OAAI
Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial

在1期试验中,间皮素特异性嵌合抗原受体T细胞对胰腺癌转移的活性

2018-07-01382
OAAI
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

慢性淋巴细胞白血病对CD19嵌合抗原受体 (CAR) T细胞治疗的反应和抵抗的决定因素

2018-04-301.3K
OAAI
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma
2018-04-19133
OAAI